Glass Health

Name: Glass Health
Brand: Glass Health

AI Native

We empower healthcare providers with the best-in-class AI scribing and clinical decision support.

Est 2021|Raised $7M

LinkedIn 6K|Web traffic 58K|FTEs 22|HQ San Francisco, California, US

Published Jul 14, 2026

01Common complaints

- You need documented enterprise security artifacts immediately: if procurement requires an available SOC 2 Type II report, ISO certification proof, penetration-test summaries, and a clearly published BAA policy, expect additional diligence work based on the public documentation reviewed for this report. - Your primary need is an ambient scribe only with turnkey EHR push: products focused solely on documentation and EHR push mechanisms may be simpler options. - You manage complex multi-system patients and require highly reliable nuance in differential generation: independent evaluator commentary suggests the product performs better on straightforward cases than very complex ones. - You require fully integrated medication dosing and interaction checking as a core workflow: traditional references or specialized medication tools may be more appropriate.

Deal disqualifiers (poor fit)

Organizations requiring publicly documented SOC 2/ISO certificates, detailed penetration test reports, or strict data residency guarantees prior to vendor engagement.
Use cases that require specialist medication dosing calculators and highly validated treatment pathways as primary workflows.

From independent evaluator (The Clinical AI Report)

Limited breadth compared with full CDS expectations (for example, medication dosing and more advanced clinical decision rules).

From public documentation gaps

Security and compliance details (SOC 2/ISO, penetration-test reporting, data residency) were not clearly published in the sources accessed for this report.

Roadmap / feature maturity ambiguity

Some third-party sources reported that EHR integration was not available at specific earlier testing times, while vendor pages now indicate integration capabilities. Integration availability appears to be customer- and timeline-dependent; buyers should request demonstrations and reference customers using the same EHR.

02Why they buy

Observed or reported advantages

Utility for education and training: third-party evaluator quotes indicate usefulness for trainees and for broadening differentials in common cases.
Vendor-claimed differentiation: retrieval over guidelines/literature with inline citations for clinical Q&A, a Developer API for embedding clinical AI, and a SMART on FHIR integration approach (these are vendor claims and should be validated by buyers).

Areas where competitors may have an advantage

Enterprise ambient scribe vendors generally provide more mature administrative controls, QA tooling, analytics, contractual compliance documentation, and proven large-scale integrations.
Traditional reference tools maintain curated editorial processes and explicit content provenance.

Why customers chose Glass (as suggested by sources)

Free beta access as reported by some sources.
The vendor describes a user interface and reports usefulness for broadening differential diagnoses in straightforward cases and for educational purposes.
Vendor positions the product as using retrieval over guidelines and literature with inline citations for clinical Q&A (vendor claim).

03Field reports

Review platform coverage reality check

- Gartner Peer Insights: a search was attempted; no accessible Gartner Peer Insights review page for Glass Health was found in the sources accessed (it may be absent or inaccessible behind login/paywall). - G2 / TrustRadius / Capterra: searches were performed but no credible, directly relevant listing pages with review content for Glass Health were found in the accessible results. Many results were unrelated due to name collisions. Because mainstream B2B review platforms were not reliably accessible for this product, this report relies more on independent write-ups, press coverage, and limited community mentions.

Independent review quotes (The Clinical AI Report)

The Clinical AI Report published an evaluation summary (based on a modest sample of physician reviewers, per that site) and includes named/attributed quotes: - Positive/qualified: - "Helpful for training. It broadens my differential and occasionally catches something I missed. As a resident learning clinical reasoning, the free access is great. I don't think attendings with complex patients would find it sufficient on its own." — Dr. P. Patel, Internal Medicine Resident - Critical: - "...it's too narrow — no EHR integration, no evidence linking, no drug dosing. The differentials are reasonable for bread-and-butter presentations but miss nuance on complex cases. It needs to mature significantly before it's a real CDS tool." — Dr. M. Johnson, Attending Physician Note: The Clinical AI Report is a niche evaluator rather than a mass-market review platform; it provides structured critique but its sample and methodology should be considered when interpreting findings.

Reddit / community mentions

Reddit results mentioning Glass Health were limited and largely promotional in nature (for example, posts describing it as a tool for healthcare without detailed firsthand pros/cons). This limits the ability to weigh high-signal user complaints from community channels.

Why some customers might leave / choose alternatives

Based on The Clinical AI Report critique and general competitive dynamics:

Need for deeper or proven EHR integration, medication dosing, broader clinical breadth, and enterprise governance.
Preference for an ambient scribe with documented enterprise deployments or a specialized evidence engine.

Availability of detailed public case studies

In the sources accessed, there were limited concrete, named customer case studies that included baseline vs post metrics, methodology, implementation timelines, and independent validation.

Vendor claims that need verification

Vendor pages include claims such as: - Clinician adoption across multiple regions (vendor-stated) - Strong performance on clinical benchmarks and a reported low API error rate (vendor-stated) Critical notes: - Specific claims (for example, an advertised API error rate) lack publicly disclosed methodology in the sources accessed (e.g., how “error” is defined, what the denominator is, severity thresholds). - Mentions of prestigious institutions may refer to individual users or pilots rather than paid enterprise deployments. Buyers should request referenceable customers and detailed deployment scope.

04Best fit

Company sizes

Individuals / small practices: may be attracted by a free tier and self-serve onboarding.
Mid-market clinics: possible fit if EHR integration and security requirements can be met.
Large health systems: potential fit primarily via enterprise plans and API engagements, contingent on security certifications, integration maturity, and clinical governance.

Industries / verticals

Ambulatory care, hospital medicine, urgent care, and teaching hospitals (based on reported utility for training and straightforward clinical cases).

Roles and personas

Decision makers: CMIO, CTO/VP Engineering (for API), Compliance/Security, department chiefs
End users: attending physicians, residents, advanced practice providers, medical students

Qualification criteria (good fit)

Teams that can operationalize policies requiring review of AI-generated outputs.
Organizations that value a single tool that combines clinical reference Q&A, differential generation, and note drafting.

05The pitch

What the product does (core value proposition)

Glass Health is a clinician-focused AI product built around clinical decision support (CDS) and ambient scribing. Core workflows described by the vendor include: - Clinical reference Q&A ("Consult") that searches medical literature and guidelines and returns answers with citations according to the vendor. - Differential diagnosis and assessment/plan drafting from a free-text patient summary. - Ambient scribing that records during encounters and generates documentation (history & physical, progress notes, discharge summaries, patient handouts, etc.). - Developer API for embedding the vendor's AI agent into other healthcare products (EHRs, telehealth, workflow apps). (The above are vendor-stated capabilities; independent validation varies by feature and is discussed below.) **Target market & positioning** - Primary users: physicians, trainees (residents/medical students), and clinical teams seeking point-of-care synthesis and/or documentation support. - Secondary users: healthtech/EHR/telehealth vendors via the Developer API. - Market positioning: the vendor describes the product as an AI agent focused on healthcare that combines a large language model (LLM) with retrieval over guidelines and literature; this description is presented as a vendor claim.

Get a comprehensive analysis of Glass Health including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Jul 14, 2026

01Common complaints

You need documented enterprise security artifacts immediately: if procurement requires an available SOC 2 Type II report, ISO certification proof, penetration-test summaries, and a clearly published BAA policy, expect additional diligence work based on the public documentation reviewed for this report.
Your primary need is an ambient scribe only with turnkey EHR push: products focused solely on documentation and EHR push mechanisms may be simpler options.
You manage complex multi-system patients and require highly reliable nuance in differential generation: independent evaluator commentary suggests the product performs better on straightforward cases than very complex ones.
You require fully integrated medication dosing and interaction checking as a core workflow: traditional references or specialized medication tools may be more appropriate.

Deal disqualifiers (poor fit)

Organizations requiring publicly documented SOC 2/ISO certificates, detailed penetration test reports, or strict data residency guarantees prior to vendor engagement.
Use cases that require specialist medication dosing calculators and highly validated treatment pathways as primary workflows.

From independent evaluator (The Clinical AI Report)

Limited breadth compared with full CDS expectations (for example, medication dosing and more advanced clinical decision rules).

From public documentation gaps

Security and compliance details (SOC 2/ISO, penetration-test reporting, data residency) were not clearly published in the sources accessed for this report.

Roadmap / feature maturity ambiguity

Some third-party sources reported that EHR integration was not available at specific earlier testing times, while vendor pages now indicate integration capabilities. Integration availability appears to be customer- and timeline-dependent; buyers should request demonstrations and reference customers using the same EHR.

02Why they buy

Observed or reported advantages

Utility for education and training: third-party evaluator quotes indicate usefulness for trainees and for broadening differentials in common cases.
Vendor-claimed differentiation: retrieval over guidelines/literature with inline citations for clinical Q&A, a Developer API for embedding clinical AI, and a SMART on FHIR integration approach (these are vendor claims and should be validated by buyers).

Areas where competitors may have an advantage

Enterprise ambient scribe vendors generally provide more mature administrative controls, QA tooling, analytics, contractual compliance documentation, and proven large-scale integrations.
Traditional reference tools maintain curated editorial processes and explicit content provenance.

Why customers chose Glass (as suggested by sources)

Free beta access as reported by some sources.
The vendor describes a user interface and reports usefulness for broadening differential diagnoses in straightforward cases and for educational purposes.
Vendor positions the product as using retrieval over guidelines and literature with inline citations for clinical Q&A (vendor claim).

03Field reports

Review platform coverage reality check

Gartner Peer Insights: a search was attempted; no accessible Gartner Peer Insights review page for Glass Health was found in the sources accessed (it may be absent or inaccessible behind login/paywall).
G2 / TrustRadius / Capterra: searches were performed but no credible, directly relevant listing pages with review content for Glass Health were found in the accessible results. Many results were unrelated due to name collisions.

Because mainstream B2B review platforms were not reliably accessible for this product, this report relies more on independent write-ups, press coverage, and limited community mentions.

Independent review quotes (The Clinical AI Report)

The Clinical AI Report published an evaluation summary (based on a modest sample of physician reviewers, per that site) and includes named/attributed quotes:

Positive/qualified:
- "Helpful for training. It broadens my differential and occasionally catches something I missed. As a resident learning clinical reasoning, the free access is great. I don't think attendings with complex patients would find it sufficient on its own." — Dr. P. Patel, Internal Medicine Resident
Critical:
- "...it's too narrow — no EHR integration, no evidence linking, no drug dosing. The differentials are reasonable for bread-and-butter presentations but miss nuance on complex cases. It needs to mature significantly before it's a real CDS tool." — Dr. M. Johnson, Attending Physician

Note: The Clinical AI Report is a niche evaluator rather than a mass-market review platform; it provides structured critique but its sample and methodology should be considered when interpreting findings.

Reddit / community mentions

Reddit results mentioning Glass Health were limited and largely promotional in nature (for example, posts describing it as a tool for healthcare without detailed firsthand pros/cons). This limits the ability to weigh high-signal user complaints from community channels.

Why some customers might leave / choose alternatives

Based on The Clinical AI Report critique and general competitive dynamics:

Need for deeper or proven EHR integration, medication dosing, broader clinical breadth, and enterprise governance.
Preference for an ambient scribe with documented enterprise deployments or a specialized evidence engine.

Availability of detailed public case studies

In the sources accessed, there were limited concrete, named customer case studies that included baseline vs post metrics, methodology, implementation timelines, and independent validation.

Vendor claims that need verification

Vendor pages include claims such as:

Clinician adoption across multiple regions (vendor-stated)
Strong performance on clinical benchmarks and a reported low API error rate (vendor-stated)

Critical notes:

Specific claims (for example, an advertised API error rate) lack publicly disclosed methodology in the sources accessed (e.g., how “error” is defined, what the denominator is, severity thresholds).
Mentions of prestigious institutions may refer to individual users or pilots rather than paid enterprise deployments. Buyers should request referenceable customers and detailed deployment scope.

04Best fit

Company sizes

Individuals / small practices: may be attracted by a free tier and self-serve onboarding.
Mid-market clinics: possible fit if EHR integration and security requirements can be met.
Large health systems: potential fit primarily via enterprise plans and API engagements, contingent on security certifications, integration maturity, and clinical governance.

Industries / verticals

Ambulatory care, hospital medicine, urgent care, and teaching hospitals (based on reported utility for training and straightforward clinical cases).

Roles and personas

Decision makers: CMIO, CTO/VP Engineering (for API), Compliance/Security, department chiefs
End users: attending physicians, residents, advanced practice providers, medical students

Qualification criteria (good fit)

Teams that can operationalize policies requiring review of AI-generated outputs.
Organizations that value a single tool that combines clinical reference Q&A, differential generation, and note drafting.

05The pitch

What the product does (core value proposition)

Glass Health is a clinician-focused AI product built around clinical decision support (CDS) and ambient scribing. Core workflows described by the vendor include:

Clinical reference Q&A ("Consult") that searches medical literature and guidelines and returns answers with citations according to the vendor.
Differential diagnosis and assessment/plan drafting from a free-text patient summary.
Ambient scribing that records during encounters and generates documentation (history & physical, progress notes, discharge summaries, patient handouts, etc.).
Developer API for embedding the vendor's AI agent into other healthcare products (EHRs, telehealth, workflow apps).

(The above are vendor-stated capabilities; independent validation varies by feature and is discussed below.)

Target market & positioning

Primary users: physicians, trainees (residents/medical students), and clinical teams seeking point-of-care synthesis and/or documentation support.
Secondary users: healthtech/EHR/telehealth vendors via the Developer API.
Market positioning: the vendor describes the product as an AI agent focused on healthcare that combines a large language model (LLM) with retrieval over guidelines and literature; this description is presented as a vendor claim.

Get a comprehensive analysis of Glass Health including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →